Special issue of Psicoterapia Cognitiva e Comportamentale
Applications of Schema Therapy to psychopathological disorders: efficacy, processes of change, and methodological issues
Guest Editors: Ezio Sanavio; Harold Dadomo
All articles will be published online in English, on an open-access basis, and assigned a DOI.
Background and aims
Schema Therapy (ST) is an integrative psychotherapeutic approach originally developed for the treatment of personality disorders and complex psychological problems. More recently, its use has been proposed as a complementary approach to other treatments, particularly Cognitive Behavioral Therapy (CBT), to address underlying vulnerability factors rooted in early experiences that contribute to major psychopathological conditions (e.g., Eating Disorders, Obsessive-Compulsive Disorder, etc.).
This special issue aims to bring together scientific contributions addressing treatment efficacy, processes of change, assessment instruments, the validity of theoretical constructs, and methodological issues concerning the applications of Schema Therapy in these contexts.
Contributions that help clarify for which patients, through which processes, and under what conditions Schema Therapy may produce clinically meaningful benefits, even in the absence of personality disorder, are particularly encouraged. The aim is to evaluate its clinical potential, limitations, and conditions of applicability, without assuming a priori that the model will be confirmed. Accordingly, the special issue also welcomes replication studies and studies reporting null results.
Topics of interest
Submissions may address the following topics. The areas listed below do not exclude other proposals consistent with the aims of the special issue.
Efficacy and comparative outcomes
Randomized controlled trials and comparative studies of Schema Therapy applied to psychopathological disorders; evaluations of efficacy under controlled conditions and in routine clinical settings; comparisons with other evidence-based psychotherapeutic treatments. This area includes the maintenance of treatment effects, relapses, and long-term outcomes, considering remission, functional recovery, quality of life, and other patient-relevant outcomes. Cost evaluations, cost-effectiveness analyses, and assessments of treatment sustainability, as well as systematic reviews and meta-analyses, are also relevant.
Processes and mechanisms of change
Studies investigating processes that accompany or precede clinical improvement, with particular attention to changes in schemas and modes and the role of relational processes. Contributions that distinguish associations between a process and therapeutic outcomes from the evidence required to attribute a causal role to that process are encouraged. The adequacy of research designs and measures used is a central aspect in evaluating the proposed mechanisms.
Theoretical Validity and Construct Measurement
Investigations into the empirical validity of the core constructs of Schema Therapy, the structure, stability, and modifiability of schemas and modes, and the psychometric properties of assessment instruments. Studies addressing the convergent, discriminant, and predictive validity of measures, their relationships with contemporary models of psychopathology, and comparisons between alternative theoretical hypotheses are of interest. This area also includes the replicability of findings and the cross-cultural generalizability of constructs and measures.
Clinical applications and personalization
Studies of Schema Therapy across different psychopathological conditions, not limited to personality disorders, and in complex clinical conditions, including those involving comorbidity, interpersonal difficulties, and psychosocial impairment. Relevant topics include the identification of predictors and moderators of treatment response, the personalization of interventions, and the evaluation of adaptations for different age groups and clinical settings.
Methodological issues
Contributions addressing the quality of comparisons between treatments, the assessment of treatment fidelity, and the appropriateness of measures in relation to research objectives. Papers examining the limitations of research designs and the implications of these limitations for conclusions regarding efficacy, processes, and mechanisms of change are encouraged, contributing to the development of transparent, replicable, and cumulative research.
Types of contributions
Submissions are invited for empirical research articles, systematic reviews and meta-analyses, and clinical case reports, which must necessarily illustrate specific and lesser-known applications of Schema Therapy. Empirical research may employ quantitative, qualitative, or mixed methods and may include psychometric studies, studies of therapeutic processes, and replications of previous research.
Manuscripts must make an identifiable scientific contribution to the stated aims and comply with the journal’s editorial and ethical guidelines (link: Instructions for Authors). The relevance of each contribution will also be assessed in terms of its ability to verify previous findings or to delineate the conditions under which the hypotheses examined are valid.
Manuscript submission and evaluation
Manuscripts must be written in English and will undergo the journal’s standard peer-review process. Selection will be based on scientific quality, methodological rigor, theoretical and clinical relevance, and transparency of reporting. The evaluation will consider the consistency between research questions, methods, results, and conclusions, regardless of the direction of the findings.
Submission deadline: July 1, 2027
Submission procedure: Please visit the Instructions for Authors on the journal’s website.
Editorial contact: [email protected]